https://orcid.org/0000-0002-6320-2457
References
- Xu JZ, Thein SL. The carrier state for sickle cell disease is not completely harmless. Haematologica. 2019;104(6):1106–1111.
- Key NS, Derebail VK. Sickle-cell trait: novel clinical significance. Hematology Am Soc Hematol Educ Program. 2010;2010:418–422.
- Thein SL. Molecular basis of β thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018;70:54–65.
- Belisário AR, Carneiro-Proietti AB, Sabino E, et al. Hb S/β-thalassemia in the REDS-III Brazil sickle cell disease cohort: clinical, laboratory and molecular characteristics. Hemoglobin. 2020;44(1):1–9.
- National Center for Biotechnology Information-ClinVar, 1988. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000256345.5.
- Bain BJ, Editor. Haemoglobinopathy Diagnosis, 3rd ed. Hoboken (NJ): Wiley Blackwell; 2020.
- El-Kamah GY, Amr KS. Thalassemia from genotype to phenotype. In: Munshi A, Editor. Thalassemia – From Genotype to Phenotype, Inherited Hemoglobin Disorders, 4th ed. Rijeka (Croatia); IntechOpen. 2015. p. 13–34.
- AlMosawi RHN, Al-Rashedi NAM, Ayoub NI. Clinical laboratory manifestation and molecular diagnosis of β-thalassemia patients in Iraq. J Pediatr Hematol Oncol. 2020;42(1):27–31.
- Geva A, Clark JJ, Zhang Y, et al. Hemoglobin Jamaica plain-a sickling hemoglobin with reduced oxygen affinity. N Engl J Med. 2004;351(15):1532–1538.
- Jorge SED, Petruk AA, Kimura EM, et al. Hb S-São Paulo: a new sickling hemoglobin with stable polymers and decreased oxygen affinity. Arch Biochem Biophys. 2012;519(1):23–31.
- Monplaisir N, Merault G, Poyart C, et al. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A. 1986;83(24):9363–9367.
- Giardine BM, Joly P, Pissard S, et al. Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2021;49(D1):D1192–D1196.
- Sahoo SS, Biswal S, Dixit M. Distinctive mutation spectrum of the HBB gene in an urban eastern Indian population. Hemoglobin. 2014;38(1):33–38.
- Chauhan W, Afzal M, Zaka-Ur-Rab Z, et al. A novel frameshift mutation, deletion of HBB:c.199_202delAAAG [codon 66/67 (–AAAG)] in β-thalassemia major patients from the western region of Uttar Pradesh, India. Appl Clin Genet. 2021;14:77–85.
- Vucak J, Turudic D, Milosevic D, et al. Genotype-phenotype correlation of β-thalassemia in Croatian patients: a specific HBB gene mutations. J Pediatr Hematol Oncol. 2018;40(2):e77–e82.
- Pauzy LHM, Jalil N, Sabudin RZAR, et al. Case series of IVS-II-666 (C>T) (HBB: c.316-185C>T) polymorphism: experience from a single referral center in Malaysia. Hemoglobin. 2019;43(6):356.